covid
Buscar en
Progresos de Obstetricia y Ginecología
Toda la web
Inicio Progresos de Obstetricia y Ginecología Cáncer de cérvix en mujeres menopáusicas. ¿Es válida la actual estrategia d...
Journal Information
Vol. 47. Issue 12.
Pages 554-560 (January 2004)
Share
Share
Download PDF
More article options
Vol. 47. Issue 12.
Pages 554-560 (January 2004)
Full text access
Cáncer de cérvix en mujeres menopáusicas. ¿Es válida la actual estrategia de cribado?
Cervical cancer in menopausal women. Is the current screening strategy adequate?
Visits
3322
A. Calvoa,
Corresponding author
acalvo@hospitalmanacor.org

Correspondencia: Ctra. Manacor-Alcudia s/n. 07500 Manacor. Baleares. España
, J. Agüerab, I. Matanzasc
a Jefe de Servicio. Servicio de Ginecología y Obstetricia. Hospital de Manacor. Baleares
b Jefe de Sección. Servicio de Ginecología y Obstetricia. Hospital de Manacor. Baleares
c Jefe de Servicio. Servicio de Anatomía Patológica. Hospital de Manacor. Baleares. España
This item has received
Article information
Resumen
Objetivo

Valorar la cobertura poblacional y analizar los resultados citológicos.

Material y método

Se revisan todas las citologías vaginales efectuadas en nuestro centro entre enero de 1998 y diciembre de 2001.

Resultados

El cáncer invasivo es más frecuente en mujeres de más de 50 años (75% de los casos), frente a sólo el 25% entre las mujeres menores de 50 años (p < 0,001).

Conclusiones

El cáncer de cérvix tiene mayor incidencia entre mujeres menopáusicas insuficientemente controladas, por lo que las mujeres mayores de 65 años deben ser consideradas de riesgo mientras no se les practiquen 2 citologías con un intervalo anual.

Palabras Clave:
Cáncer de cérvix
Menopausia
Cribado
Abstract
Objective

To evaluate population coverage of screening for cervical cancer and analyze cytological results.

Material and method

All the pap smears taken in our hospital between January 1998 and December 2001 were reviewed.

Results

Invasive cervical cancer was more frequent among women aged more than 50 years old (75% of the cases) than among those aged less than 50 years (25%; p<0.001).

Conclusions

The incidence of cervical cancer is greater among menopausal women who are insufficiently screened. Consequently, women aged more than 65 years old should be considered at risk unless 2 smears have been taken 1 year apart.

Key Words:
Cervical cancer
Menopause
Screening
Full text is only aviable in PDF
Bibliografía
[1.]
Cancer Incidence in five continents. Vol. VIII. IARC Scientific Publications N.° 155,
[2.]
Pla de Salut de les Illes Balears 2003–2007.
Govern de les Illes Balears. Conselleria de Salut i Consum.
Direcció General de Salut Pública, (2003),
[3.]
Quaderns de Càncer de les Illes Balears.
Q1, (2002),
[4.]
Documentos de Consenso de la SEGO.
pp. 41-105
[5.]
Conferencia de Consenso sobre Prevención del Cáncer Genital Femenino.
Sociedad Española de Ginecología y Obstetricia (SEGO).
(1977),
[6.]
D. Solomon, D. Daye, R. Kurman, A. Moriarty, D. O’Connor, M. Prey, et al.
The Bethesda System. Terminology for reporting results of cervical pathology.
Jama, 287 (2002), pp. 2114-2119
[7.]
Enquesta de Salut de les Illes Balears.
Govern de les Illes Balears. Conselleria de Salut i Consum.
Direcció General de Salut Publica, (2003),
[8.]
M.A. Duggan, S.E. Mcgregor, G.C. Stuart, S. Morris, V.S. Chang-Pon, A. Schepansky, et al.
The natural history of CIN I lessions.
Eur J Gynecol Oncol, 19 (1998), pp. 338-344
[9.]
W. Kinney, H.Y. Sung, K.A. Kearney, M. Miller, G. Sawaya, R.A. Hiatt.
Missed opportunities for cervical cancer screening of HMO members developing invasive cervical cancer.
Gynecol Oncol, 71 (1998), pp. 428-430
[10.]
P. Sasieni, J. Adams, J. Cuzick.
Benefits of cervical screening at different ages: evidence from the UK. Audit on screening histories.
Br J Cancer, 89 (2003), pp. 88-93
[11.]
T.J. Colgan, A. Clarke, N. Hakn, A. Seidenfeld.
Screening for cervical disease in mature women: strategies for improvement.
Cancer, 96 (2002), pp. 195-203
[12.]
D. Saslow, C.D. Runowicz, D. Solomon, A.B. Moscicki, R.A. Smith, H.J. Eyre, et al.
American Cancer Society guideline for the early detection of cervical neoplasia and cancer.
CA Cancer J Clin, 52 (2002), pp. 342-362
[13.]
E.J. Parboosingh, G. Anderson, E.A. Clarke, S. Inhaber, E. Kaegi, C. Mills, et al.
Cervical cancer screening: are the 1989 recommendations still valid?.
Can Med Assoc J, 154 (1996), pp. 1847-1853
[14.]
P. Sasieni, J. Adams.
Effect of screening on cervical cancer mortality in England and Wales: analysis of trends with an age period cohort model.
Bmj, 318 (1999), pp. 1244-1245
[15.]
J. Austoker.
Cancer prevention in primary care screening for cervical cancer.
Bmj, 309 (1994), pp. 241-248
[16.]
J.C. Hyndman, J.A. Straton, D.A. Pritchard, H. Le Seur.
Cost-effectiveness of interventions to promote cervical screening in general practice.
Aust N Z J Public Health, 20 (1996), pp. 272-277
[17.]
G. Matsunaga, I. Tsuji, S. Sato, A. Fukao, S. Hisamichi, Yajima.
Cost-effective analysis of mass screening for cervical cancer in Japan.
J Epidemiol, 7 (1997), pp. 135-141
[18.]
P. Davies, J. Kornegay, T. Iftner.
Current methods of testing for human papilomavirus.
Baillieres Best Pract Res Clin Obstet Gynaecol, 15 (2001), pp. 677-700
[19.]
C. Clavel, M. Masure, J.P. Bory, I. Putaud, C. Mangeonjean, M. Lorenzato, et al.
Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women.
Br J Cancer, 84 (2001), pp. 1616-1623
[20.]
M. Moscarini, A. Lukic, C. Franco.
Anti human papillomavirus vaccine: the checkmate to human papillomavirus.
Eur J Gynaecol Oncol, 25 (2004), pp. 151-156
[21.]
L.A. Koutsky, K.A. Ault, C.M. Wheeler, D.R. Brown, E. Barr, F.B. Alvarez, et al.
Proof of Principle Study Investigators. A controlled trial of a human papillomavirus type 16 vaccine.
N Engl J Med, 347 (2002), pp. 1645-1651
Copyright © 2004. Sociedad Española de Ginecología y Obstetricia
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos